Faldt; Andre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Faldt; Andre.The latest application filed is for "1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity fo".

Company Profile

0.13.13

Faldt; Andre - Ishoj DK
Faldt; Andre - Ballerup DK
Faldt; Andre - Vejlebrovej DK
Faldt; Andre - Valby DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine As A Compound With Combined Serotonin Reuptake, 5-ht3 And 5-ht1a Activity Fo App 20200163959 - Faldt; Andre ; et al.	2020-05-28
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine As A Compound With Combined Serotonin Reuptake, 5-ht3 And 5-ht1a Activity For The Treatment Of Cognitive Impairment App 20180333408 - Faldt; Andre ; et al.	2018-11-22
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds Grant 9,908,894 - Metzler , et al. March 6, 2	2018-03-06
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT.sub.3 and 5-HT.sub.1A activity for the treatment of cognitive impairment Grant 9,861,630 - Faldt , et al. January 9, 2	2018-01-09
1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT App 20170360777 - Faldt; Andre ; et al.	2017-12-21
Methods For The Preparation Of 1,3-benzodioxole Heterocyclic Compounds App 20170137438 - Metzler; Bjorn ; et al.	2017-05-18
Crystalline Forms Of 4-[2-(4-methylphenylsulfanyl)-phenyl] Piperidine App 20170037006 - Bang-Andersen; Benny ; et al.	2017-02-09
Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine Grant 9,315,459 - Bang-Andersen , et al. April 19, 2	2016-04-19
1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT App 20160083359 - Bang-Andersen; Benny ; et al.	2016-03-24
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment Grant 9,227,946 - Faldt , et al. January 5, 2	2016-01-05
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT.sub.3 and 5-HT.sub.1A activity for the treatment of cognitive impairment Grant 9,125,909 - Bang-Andersen , et al. September 8, 2	2015-09-08
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT.sub.3 and 5-HT.sub.1A activity for the treatment of cognitive impairment Grant 9,125,910 - Bang-Andersen , et al. September 8, 2	2015-09-08
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT.sub.3 and 5-HT.sub.1A activity for the treatment of cognitive impairment Grant 9,125,908 - Bang-Andersen , et al. September 8, 2	2015-09-08
Process for preparing 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or pharmaceutically acceptable salt thereof Grant 9,101,626 - Faldt , et al. August 11, 2	2015-08-11
Process for preparing 1-[2-(2,4-dimethylphenysulfanyl)-pheny]piperazine or pharmaceutically acceptable salt thereof Grant 9,095,588 - Faldt , et al. August 4, 2	2015-08-04
Crystalline Forms Of 4-[2-(4-methylphenylsulfanyl)-phenyl] Piperidine App 20150073018 - Bang-Andersen; Benny ; et al.	2015-03-12
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment Grant 8,969,355 - Bang-Andersen , et al. March 3, 2	2015-03-03
1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment App 20140371453 - Faldt; Andre ; et al.	2014-12-18
1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment App 20140315921 - Bang-Andersen; Benny ; et al.	2014-10-23
1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment App 20140256943 - Faldt; Andre ; et al.	2014-09-11
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment Grant 8,722,684 - Bang-Andersen , et al. May 13, 2	2014-05-13
Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereof Grant 8,299,095 - Bang-Andersen , et al. October 30, 2	2012-10-30
4-[2,3-Difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine App 20110039890 - Bang-Andersen; Benny ; et al.	2011-02-17
1- [2- (2,4-dimethylphenylsulfanyl)-phenyl] Piperazine As A Compound With Combined Serotonin Reuptake, 5-ht3 And 5-ht1a Activity For The Treatment Of Cognitive Impairment App 20100297240 - Bang-Andersen; Benny ; et al.	2010-11-25
Crystalline Forms Of 4- [2- (4-methylphenylsulfanyl) -phenyl] Piperidine With Combined Serotonin And Norepinephrine Reuptake Inhibition For The Treatment Of Neuropathic Pain App 20090264465 - Bang-Andersen; Benny ; et al.	2009-10-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.